Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Ollin raises $330 million to fund late-stage eye disease drug trials reut.rs/3SEFHMv https://reut.rs/3SEFHMv
2026-06-24T11:15:18.963Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.